New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary diseaseBusiness Wire • 1h
BenevolentAI and AstraZeneca discover novel heart failure target using AIProactive Investors • Wednesday
Eli Lilly's and AstraZeneca's Former Head of Research Dr. Jan Lundberg Elected as a New Board MemberAccesswire • Wednesday
AstraZeneca to withdraw its COVID-19 vaccine globally as demand dips, rare side effects revealedFox Business • 05/08/24
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominanceCNBC • 05/07/24
Inocras Hong Kong Limited, in Collaboration with Cancerinformation.com.hk Charity Foundation and Sponsored by AstraZeneca Hong Kong, Offers Free BRCA or HRD Genetic Testing for Eligible Cancer Patients in Hong Kong and MacauBusiness Wire • 05/07/24